CGON
CGON
NASDAQ · Biotechnology

Cg Oncology Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$68.72
+2.99 (+4.55%)
As of Jun 24, 8:35 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -47.7% upside
Low Target $23.54
Average Target $35.94
High Target $41.91
Current Price $68.72
Current
$68.72
Target
$35.94
$23.54 $35.94 avg $41.91
Scenario Analysis
Bear Case
$23.54
-65.7%
Low target
Base Case
$35.94
-47.7%
Avg target
Bull Case
$41.91
+-39.0%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$75.50
-9.0% from high
52-Week Low
$23.65
+190.6% from low
50-Day SMA
$47.74
+43.9% vs SMA
200-Day SMA
$36.07
+90.5% vs SMA
RSI (14)
57.5
Neutral
Target vs 52W High
$35.94
-52.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.4%